SCHEMBL3124221

SCHEMBL3124221

CCN1CCC(O)(c2ccc(F)cc2F)C1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MC4R P32245 1/20 0.40
DRD2 P14416 8/20 0.39
L3MBTL1 Q9Y468 1/20 0.38
OPRM1 P35372 3/20 0.37
SIGMAR1 Q99720 3/20 0.37
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 1/20 0.37
LMNA P02545 1/20 0.37
DRD4 P21917 2/20 0.37
DRD3 P35462 2/20 0.37
HSD11B1 P28845 1/20 0.36
OPRL1 P41146 2/20 0.36
ALDH1A1 P00352 1/20 0.36
HTR2A P28223 2/20 0.36
HTR2C P28335 2/20 0.36
HTR1A P08908 1/20 0.36
ADRA2A P08913 1/20 0.36
ADRA2B P18089 1/20 0.36
ADRA2C P18825 1/20 0.36
ADRA1A P35348 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3113630 0.89 DRD2 (0.42) DRD2OPRM1SIGMAR1KCNH2LMNA
SCHEMBL3121837 0.87 DRD2 (0.43) DRD2SIGMAR1DRD4DRD3HTR2A
SCHEMBL3119785 0.86 DRD2 (0.47) DRD2DRD4DRD3OPRL1HTR2A
SCHEMBL3123786 0.86 DRD2 (0.42) DRD2DRD4DRD3OPRL1HTR2A
SCHEMBL3113311 0.85 CYP2D6 (0.46) MC4RDRD2OPRM1DRD4DRD3
SCHEMBL3124015 0.83 HDAC1 (0.42) MC4RDRD2KCNH2DRD4DRD3
SCHEMBL3118604 0.82 TSHR (0.41) DRD2SIGMAR1DRD4DRD3OPRL1
SCHEMBL1822721 0.81 KMT2A (0.54) KDM4EOPRL1
SCHEMBL3117016 0.81 MAPK1 (0.39) DRD2OPRM1OPRL1
SCHEMBL16838121 0.77 MAPK1 (0.43) DRD2L3MBTL1OPRM1DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155671-B1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION INTEGRATIVE RES LABORATORIES SWEDEN AB (SE) 2017-12-20 EP disclosed
US-8188301-B2 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission NSAB, FILIAL AF NEUROSEARCH SWEDEN AB, SVERIGE (DK) 2012-05-29 US disclosed
US-20100179211-A1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION NSAB, FILIAL AF NEUROSEARCH SWEDEN AB (DK) 2010-07-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100179211-A1 DISUBSTITUTED PHENYLPYRROLIDINES AS MODULATORS OF CORTICAL CATECHOLAMINERGIC NEUROTRANSMISSION PNMT, DBH, SLC6A2 MC4R 448/4885DRD2 9/4885L3MBTL1 2803/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.